Frederik Meijer Heart & Vascular Institute Cardiovascular Research — Grand Rapids, Michigan

Frederik Meijer Heart & Vascular Institute Cardiovascular Research is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Frederik Meijer Heart & Vascular Institute Cardiovascular Research has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Grand Rapids

Browse all research sites in Michigan · View every site in Grand Rapids

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Frederik Meijer Heart & Vascular Institute Cardiovascular Research?

Frederik Meijer Heart & Vascular Institute Cardiovascular Research has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Frederik Meijer Heart & Vascular Institute Cardiovascular Research conducted?

Frederik Meijer Heart & Vascular Institute Cardiovascular Research has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Frederik Meijer Heart & Vascular Institute Cardiovascular Research accredited by Crixeo Clinical Trials?

Frederik Meijer Heart & Vascular Institute Cardiovascular Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Frederik Meijer Heart & Vascular Institute Cardiovascular Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.